Teleflex To Divest Acute Care, Interventional Urology and OEM Units for $2.03 Billion
Proceeds will finance a $1 billion buyback, with closing targeted for the second half of 2026.
Overview
- Intersurgical will acquire the Acute Care and Interventional Urology businesses for $530 million, while Montagu and Kohlberg will buy the OEM business for about $1.5 billion, both subject to adjustments.
- Teleflex’s board approved the transactions, which are expected to close in the second half of 2026 pending customary regulatory approvals and other conditions.
- The company expects approximately $1.8 billion in after‑tax proceeds and plans to allocate cash to share repurchases and debt reduction.
- The board authorized up to $1 billion in share repurchases to be funded primarily by sale proceeds, with timing and amounts at management’s discretion.
- Teleflex says the divestitures will sharpen its focus on core high‑acuity hospital markets and strengthen its capacity to invest in innovation and commercial execution.